News

Hosted on MSN1mon
Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike - MSN
Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a label narrower than initially targeted. The vaccine will be marketed ...
CIDRAP19h
Quick takes: WHO arbovirus guidance, H5N1 in US mammals, re-blocking southern border livestock imports
Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...
Pharm Exec1mon
FDA Approves Moderna’s mNEXSPIKE COVID-19 Vaccine for High-Risk ...
FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations: Moderna’s next-generation COVID-19 vaccine, mNEXSPIKE (mRNA-1283), has received FDA approval for adults aged 65 years and older and ...
The National Law Review1mon
Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE
Moderna expects to have mNEXSPIKE available for eligible populations in the U.S. for the 2025-2026 respiratory virus season, alongside Spikevax and mRESVIA ®, the Company's approved respiratory ...
New York Post1mon
FDA approves Moderna’s next-generation COVID vaccine for adults 65 or ...
The US Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above.
Monthly Prescribing Reference1mon
FDA Approves Moderna's Next-Generation COVID-19 Vaccine mNexspike
The Food and Drug Administration has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike.